SIREN : 815376801
MEDICOOP FRANCE is a French company founded 10 years ago, specialized in the sector Activités des agences de travail temporaire . Based in PARIS (75020), this company of category PME shows in 2024 a revenue of 66.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2023 | 2022 | 2021 | 2020 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 65 982 432 € | 77 062 396 € | 74 894 734 € | 81 057 449 € | 58 632 407 € | 1 434 663 € | N/C |
| Net income | 82 902 € | 0 € | 0 € | 0 € | 0 € | 2 558 € | -2 558 € |
| EBITDA | 163 805 € | 133 896 € | -387 552 € | 791 925 € | -927 798 € | 2 068 € | -2 558 € |
| Net margin | 0.1% | 0.0% | 0.0% | 0.0% | 0.0% | 0.2% | N/C |
In 2024, MEDICOOP FRANCE achieves revenue of 66.0 M€. Over the period 2017-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +72.8%. Significant drop of -14% vs 2023. After deducting consumption (2 k€), gross margin stands at 66.0 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 164 k€, representing 0.2% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 83 k€, i.e. 0.1% of revenue. This profit can be retained or distributed to shareholders.
65 982 432 €
65 980 139 €
163 805 €
73 129 €
82 902 €
0.2%
The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 0%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Cash flow represents 0.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
0.0%
0.023%
0.224%
0.0
25.2%
In 2024, the debt ratio of MEDICOOP FRANCE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
In 2024, the financial autonomy of MEDICOOP FRANCE (0.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2024, the repayment capacity of MEDICOOP FRANCE (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 74.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
74.822
0.0
In 2024, the liquidity ratio of MEDICOOP FRANCE (74.82) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2024, the interest coverage of MEDICOOP FRANCE (0.0x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 6 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 29 days. Favorable situation: supplier credit is longer than customer credit by 23 days. WCR is negative (-47 days): operations structurally generate cash.
-8 606 748 €
6 j
29 j
0 j
-47 j
Based on 135 transactions of similar company sales (all years), the value of MEDICOOP FRANCE is estimated at 1 719 593 € (range 1 290 140€ - 3 193 563€). With an EBITDA of 163 805€, the sector multiple of 2.0x is applied. The price/revenue ratio is 0.08x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 135 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MEDICOOP FRANCE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des agences de travail temporaire
The revenue of MEDICOOP FRANCE in 2024 is 66.0 M€.
Yes, MEDICOOP FRANCE generated a net profit of 83 k€ in 2024.
The headquarters of MEDICOOP FRANCE is located in PARIS (75020), in the department Paris.
The tax return of MEDICOOP FRANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MEDICOOP FRANCE operates in the sector Activités des agences de travail temporaire (NAF code 78.20Z). See the 'Sector positioning' section above to compare the company with its competitors.